Abstract

Background: Atrial anti-tachycardia pacing (A-ATP) of the right atrium (RA) has been shown to decrease the burden of atrial fibrillation (AF) in patients with dual-chamber pacemakers. The aim of this study is to identify the novel predictors of effective A-ATP for terminating AF in patients with AF undergoing catheter ablation. Methods: This study included 41 consecutive patients undergoing a first ablation procedure for paroxysmal (PAF: n = 21) or persistent (PEF: n = 20) AF. We prospectively evaluated predictors of AF termination after A-ATP. The coefficient of variation (CoV = SD/mean × 100) of the dominant frequencies (DFs) was calculated to evaluate the variability in atrial activation. Results: AF was terminated by A-ATP in 29% of PAF and 5% of PEF patients. In these patients, simultaneous high-rate pacing from the RA and the coronary sinus (CS) terminated AF in 71% of patients, in whom the mean AF cycle length (CL) before A-ATP was longer (214 ± 23 vs. 177 ± 35 ms, p = 0.02) and became slower after A-ATP (234 ± 37 vs. 176 ± 32 ms, p < 0.01), compared to unsuccessful patients. The CoV of the DFs before A-ATP were lower in both RA (6.2 ± 2.0 vs. 15.3 ± 7.9, p = 0.02) and CS (11.0 ± 7.9 vs. 24.3 ± 9.3, p < 0.01) in successful patients. Conclusions: Simultaneous biatrial A-ATP from the RA and CS could terminate AF in patients with PAF. The predictors for successful termination include longer AF CL and higher AF stability.

Highlights

  • Atrial fibrillation (AF) is a common arrhythmia that can result in symptoms, heart failure, tachycardia-mediated cardiomyopathy, and most importantly, stroke and systemic embolism

  • In patients with Paroxysmal AF (PAF), fourteen patients presented in sinus rhythm, whereas no patients presented in sinus rhythm at the time of the procedure

  • Left atrial diameter was significantly larger in patients with Persistent AF (PeAF) compared to those with PAF (PAF vs. PeAF = 40 ± 5 vs. 46 ± 7 mm, p = 0.02)

Read more

Summary

Introduction

Atrial fibrillation (AF) is a common arrhythmia that can result in symptoms, heart failure, tachycardia-mediated cardiomyopathy, and most importantly, stroke and systemic embolism. The ‘MINimizE Right Ventricular pacing to prevent Atrial fibrillation and heart failure’ (MINERVA) multicenter randomized study described atrial anti-tachycardia pacing (A-ATP) has been shown to decrease the burden of AF in patients with bradycardia and atrial tachyarrhythmias [2]. We sought to evaluate the novel predictors of effective A-ATP for terminating AF in patients with AF undergoing catheter ablation. Atrial anti-tachycardia pacing (A-ATP) of the right atrium (RA) has been shown to decrease the burden of atrial fibrillation (AF) in patients with dual-chamber pacemakers. The aim of this study is to identify the novel predictors of effective A-ATP for terminating AF in patients with AF undergoing catheter ablation. Results: AF was terminated by A-ATP in 29% of PAF and 5% of PEF patients. The predictors for successful termination include longer AF CL and higher AF stability

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call